期刊文献+

新辅助化学治疗在原发性小细胞食管癌综合治疗中的价值 被引量:3

Significance of neoadjuvant chemotherapy in comprehensive treatment of small cell esophageal cancer
下载PDF
导出
摘要 目的:探讨新辅助化学治疗在原发性小细胞食管癌综合治疗中的作用。方法回顾性分析53例原发性小细胞食管癌临床资料,其中采用新辅助化学治疗加手术的治疗方法(观察组)29例,采用单纯手术治疗(对照组)24例。采用 Kaplan-Meier 法进行单因素分析,Cox 回归模型进行多因素分析。结果53例患者的中位生存期24(3~51)个月,观察组术后淋巴结阳性率明显低于对照组(24.1% vs.75.0%,P <0.05);观察组患者的3年生存率明显高于对照组(33.3%vs.4.5%,P <0.05)。单因素分析显示,肿瘤部位、肿瘤长度、淋巴结是否阳性及不同治疗方式与患者3年生存期有关,P 值分别为0.048、0.018、0.030及0.039。多因素分析显示,肿瘤部位、肿瘤长径、淋巴结阳性率及不同治疗方式是影响患者生存率的因素。结论新辅助化学治疗在原发性小细胞食管癌综合治疗中占有重要地位,是影响预后的重要因素。 Objective To evaluate the curative effect of neoadjuvant chemotherapy in the comprehen-sive treatment of small cell esophageal cancer.Methods Clinical data of 53 cases of small cell esophageal cancer were retrospectively analyzed.Among them,29 patients underwent neoadjuvant chemotherapy combined with surgical treatment (observation group)and 24 received surgery alone (control group).Kaplan-Meier method was used for univariate analysis and Cox regression was adopted to conduct multivariate analysis.Re-sults The median survival time of 53 cases was 24 months (3-51 months).Postoperative positive rate of lymph node in the observation group was significantly lower compared with that in the control group (24.1%vs.75.0%,P 〈0.05).The 3-year survival rate in the observation group was significantly higher than that in the control group (33.3% vs.4.5%,P 〈0.05).Univariate analysis revealed that tumor site and size,the presence of positive lymph nodes and different interventions were significantly correlated with 3-year survival rate (P =0.048,0.018,0.030 and 0.039).Multivariate analysis indicated that tumor site and size,the presence of posieive lymph nodes and different treatment was an independent prognostic factor of patients’sur-vival.Conclusion Neoadjuvant chemotherapy plays a pivotal role in the comprehensive treatment of small cell esophageal cancer and serves as a vital influencing factor of clinical prognosis.
出处 《新医学》 2015年第9期620-624,共5页 Journal of New Medicine
关键词 小细胞食管癌 新辅助化学治疗 预后 Small cell esophageal cancer Neoadjuvant chemotherapy Prognosis
  • 相关文献

参考文献14

  • 1康晓征,马少华,梁震,陈克能.小细胞食管癌的综合治疗疗效分析[J].中华胃肠外科杂志,2012,15(6):611-614. 被引量:2
  • 2Casas F, Ferrer F, Farr6s B, Casals J, Biete A. Prima- ry small cell carcinoma of the esophagu : a review of the literature with emphasis on therapy and prognosis. Canc- er, 1997, 80 (8): 1366-1372.
  • 3Sakatani T, Shimizu Y, Sugino Y, Yamasaki T, Imam- ura M, Matsui Y, Inoue T, Okubo K, Kamba T, Yo- shimura K, Ogawa O. Small cell carcinoma of the blad- der. Hinyokika Kiyo, 2014, 60 (5): 221-225.
  • 4McElnay P, Lim E. Adjuvant or neoadjuvant chemo- therapy for NSCLC. J Thorae Dis, 2014, 6 (Suppl 2): S224-S227.
  • 5Geva R, Itzkovich E, Shamai S, Shacham-Shmueli E, Soyfer V, Klausner JM, Tulchinsky H. Is there a role for adjuvant chemotherapy in pathological complete re- sponse rectal cancer tumors following neoadjuvant che- moradiotherapy? J Cancer Res Clin Oncol, 2014, 140 (9) : 1489-1494.
  • 6Zelle BA, Bhandari M, Sanchez AI, Probst C, Pape HC. Loss of follow-up in orthopaedic trauma: is 80% follow-up still acceptable? J Orthop Trauma, 2013, 27(3) : 177-181.
  • 7吕纪马,梁军,王金万,赫捷,肖泽芬,张红星,陈东福,冯勤付,王绿化.126例小细胞食管癌的临床分析[J].中华肿瘤杂志,2009,31(2):121-125. 被引量:29
  • 8刘艳辉,范英.食管小细胞未分化癌的临床病理分析及免疫组化研究:...[J].中华肿瘤杂志,1991,13(2):123-125. 被引量:17
  • 9辜树勇,林少波,傅俊惠,杜泽森.紫杉醇脂质体联合奈达铂行食管癌新辅助化学治疗的近期疗效观察[J].新医学,2013,44(5):323-325. 被引量:9
  • 10Chatni SS, Ravindran HK, Narayanan A, Balakrishnan V. Small cell carcinoma of the esophagus. Saudi J Gas- troenterol, 2008, 14 (3): 149-150.

二级参考文献40

  • 1范倩,刘巍.晚期食管鳞癌的化疗进展[J].中国肿瘤临床,2006,33(20):1196-1199. 被引量:7
  • 2林若柏,林培裘,周仑,陈椿,康明强,郑炜.食管癌淋巴结转移规律的临床研究(附200例分析)[J].中华肿瘤杂志,1996,18(4):292-295. 被引量:72
  • 3Kim JH, Lee SH, Park J, et al. Extrapulmonary small-cell carcinoma: a single-institution experience. Jpn Clin Oncol, 2004, 34 : 250- 254.
  • 4Brenner B, Tang LH, Shia J, et al. Small cell carcinomas of the gastrointestinal tract: clinicopathological features and treatment approach. Semin Oncol, 2007, 34:43-50.
  • 5Matsumoto M, Natsugoe S, Nakashima S, et al. Biological evaluation of undifferentiated carcinoma of the esophagus. Ann Surg Oncol, 2000, 7:204-209.
  • 6Bennouna J, Bardet E, Deguiral P, et al. Small cell carcinoma of the esophagus: analysis of 10 cases and review of the published data. Am J Clin Oncol, 2000, 23:455-459.
  • 7Medgyesy CD, Wolff RA, Putnam JB Jr, et al. Small cell carcinoma of the esophagus : the University of Texas M. D. Anderson Cancer Center experience and literature review. Cancer, 2000, 88 : 262- 267.
  • 8Casas F, Ferrer F, Farrds B, et al. Primary small cell carcinoma of the esophagus: a review of the literature with emphasis on therapy and prognosis. Cancer, 1997, 80:1366-1372.
  • 9Huncharek M, Muscat J. Small cell carcinoma of the esophagus : the Massachusetts General Hospital experience, 1978 to 1993. Chest, 1995, 107:179-187.
  • 10Nemoto K, Zbao HJ Goto T, et al. Radiation therapy for limited- stage small-cell esophageal cancer. Am J Clin Oncol, 2002, 25: 404-407.

共引文献56

同被引文献27

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部